Subscribe Now
Member Sign In
Rewards
Member Sign Out
Sections
About us
Research topics
Membership
Conferences
Webinars
Videos
More
Subscribe
Sign In
Sign Out
Genomics
Sequencing & screening
DNA (microarrays, NGS)
Synthetic biology
Sequencing & screening
DNA (microarrays, NGS)
Synthetic biology
Create a FREE account so you can:
Get the latest life sciences research and
industry news, delivered straight to your
inbox, for FREE.
Enter your Email Address to become a member:
Email Address:
Register
Already have an account?
Sign in
Sign in using your social networking account:
What's this?
Sign in using your social networking
account:
(What's this?)
|
« prev
1
…
11
12
13
Researchers further understanding of how circadian clock helps brain recover after injury
Children’s National Hospital researchers have found that a relatively newly discovered type of brain cell -- known as NG2-glia -- also follows a circadian rhythm, findings that potentially open new paths of investigation for the development of future traumatic brain injury therapies.
Read More
Demand for viral vectors seen outpacing capacity growth despite investment surge
The growth in demand for viral vectors is outpacing a push to add capacity, leading to predictions that the current supply shortage will continue despite investment in the space.
Read More
Single-cell sequencing reveals spatial map of immune cells in early-stage lung cancer
Using single-cell sequencing, researchers at the University of Texas MD Anderson Cancer Center have revealed a spatial map of tumor-infiltrating B cells and plasma cells that are prevalent in early-stage lung cancers, providing a basis for finding new immunotherapy targets.
Read More
Genomics profiling reveals how Zika infects immune cells, suggests antiviral target
A genomics profiling method has revealed how the Zika virus infects human dendritic cells, pointing to a potential target for therapeutic suppression of the pathogen.
Read More
New type of CAR T cells provide on-off switch to improve cell therapy safety, efficiency
Researchers at Boston University have created on and off switches for chimeric antigen receptor (CAR) T cells, enabling them to control the activity of therapies using an approved drug.
Read More
« prev
1
…
11
12
13
Conferences
More Conferences »»
Science Briefs
More articles »
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Learn More
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Learn More
Connect
Tweets by @ScienceBoard